Epstein Secrets

eps/revs tops ests & outlook edged up plus additional buyback up to $1.5B (trading +5%) • F5 Networks Q2 eps/revs better, Q3 guide up (solid growth Americas, EMEA, Japan) (trading 1.5%) • E'Trade swings to Q1 profit & tops ests as net income jumps 2x (WFC upgrades) (trading +3.2%) EFTA00370756 • Che

ar, LFL's strong (trading -0.16%) • Astrazeneca eps slightly lower than estimates, maintains guidance, pipeline update positive (trading +4.0%) • Novartis O1 core eps and net meet estimates, fx impact, sales miss, guidance reiterated (trading -1.1%) • Novozymes Q1 beats estimates, now sees 2014 net pr

ent Principal, *McChrystal*Group. Sr. Fellow, Yale's Jackson Institute for Global Affairs.* *Andrew McLaughlin**- Fmr VP, Tumblr. Fmr Deputy CTO of the United States, White House. Fmr Dir of Public Policy, Google. Boards: Public Knowledge, Code for America. * *Dmitri **Mehlhorn**- COO, *StudentsFirst*.* *Lenny

Persesus Strategies. Founder, Freedom Now. International lawyer for Aung San Suu Kyi. *Jeff George*- Global Head, Sandoz. Member of Exec Committee, Novartis. *Dave Goldberg*- CEO, SurveyMonkey. *Tom Goldstein*-- Partner, Goldstein & Howe. Fmr Partner and head of Supreme Court practice, Akin Gump. Has a

ons working closely as the Herd Leadership Team. Our Chief Executive Officer. Kurt Schmidt. has decades of leadership experience in CPG companies in the United States and overseas at Kraft, Wrigley, Novartis and Nettle, where he most recently led Nestle's 58 billion global Health & Wellness Division. Our President

ur Chief Executive Officer. Kurt Schmidt. has decades of leadership experience in CPG companies in the United States and overseas at Kraft, Wrigley, Novartis and Nettle, where he most recently led Nestle's 58 billion global Health & Wellness Division. Our President and Chief Operating Officer and co-found

s Shareholders under the CFC rules, and (ii) will be subject to the Section 1248 recharacterization rule described above. In addition, if the Fund is a United States Shareholder of a CFC and a U.S. Partner disposes of its Limited Partner Interest, that Partner generally will recognize income under Section 751 of t

bserver), Sirna Therapeutics (NASDAQ: RNAI, acquired by Merck in 2006 for $1.1 billion), where he served as Chairman; Oriel Therapeutics (acquired by Novartis in 2010), where he served as Executive Chairman, and Pearl Therapeutics (acquired by AstraZeneca in 2012). Prior to joining Sprout, Jim was Chief Sci

nt on global health expenditure in 2011. At 10%+' this represents, one of the largest sectors of global GDP. At $2.82 trillion, healthcare spend in Unites States is the largest globally and represents 172% of the US GDP. Moreover, the expenditure on healthcare has grown significantly faster than GDP in 44 of

s, improving their effectiveness but shrinking their addressable markets. Drug companies will need to adapt their marketing strategies accordingly. Novartis CEO Joe Jimenez called out the explosion in DNA sequencing as a driver for R&D productivity "allowing new areas of discovery that have never been po

ersesus Strategies. Founder, Freedom Now. International lawyer for Aung San Suu Kyi. *Jeff George*iz% Global Head, Sandoz. Member of Exec Committee, Novartis. *Dave Goldberg*1iz% CEO, SurveyMonkey. *Tom Goldstein*-- Partner, Goldstein & Howe. Fmr Partner and head of Supreme Court practice, Akin Gump. Has

McChrystal*Group. Sr. Fellow, Yaleigh%s Jackson Institute for Global Affairs.* *Andrew McLaughlin**7iz% Fmr VP, Tumblr. Fmr Deputy CTO of the United States, White House. Fmr Dir of Public Policy, Google. Boards: Public Knowledge, Code for America. * *Dmitri **Mehlhorn**7z% Coo, *StudentsFirst*.* *Lenny

ipal, *McChrystal*Group. Sr. Fellow, Yaleigh%s Jackson Institute for Global Affairs.* *Andrew McLaughlin**7iz% Fmr VP, Tumblr. Fmr Deputy CTO of the United States, White House. Fmr Dir of Public Policy, Google. Boards: Public Knowledge, Code for America. * *Dmitri **Mehlhorn**7z% Coo, *StudentsFirst*.*

hen for "insights" about the Trump administration. AT&T's admission came after a lawyer for porn star Stormy Daniels claimed the company, drug giant Novartis and a Russian oligarch had all made payments to Cohen's shell company. HOUSE_OVERSIGHT_016218 --- PAGE BREAK --- Daniels' lawyer, Michael Avenatti

it had paid Cohen, who was the president's personal lawyer at the time. AT&T is in the midst of pursuing an $85 billion acquisition of Time Warner. The U.S. Justice Department has sued to block that deal. In a report on Cohen's company, Avenatti's law firm said that Novartis in late 2017 and early 2018 m